Glycosan
Alameda
About Glycosan
Glycosan BioSystems was founded by Glenn Prestwich, William Tew, and Anna Scott in January 2006. The company received startup support from the Centers of Excellence Program for innovative research in Utah and from the University of Utah, then closed its first round of investment in May 2007. Glycosan’s patent-pending Extracel® technology was developed by the Center for Therapeutic Biomaterials at the University of Utah. Glycosan was recently acquired by BioTime, Inc (Alameda, CA) in March 2011 and is currently pursuing the clinical use of its hydrogel products for treating facial contour defects, tendon repair, degenerative disc disease, vocal fold scarring, glioma, and stroke.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Total funding: $950.0K
- Funding stage: M&A
- Last round: Series Unknown (May 2010)
- Website: glycosan.com
- Phone: 877) 636-4978
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/glycosan-2912667 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.